Australia markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2200-0.0400 (-1.23%)
At close: 04:00PM EDT
3.3500 +0.13 (+4.04%)
After hours: 07:17PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-6,002
-5,339
-9,926
-19,322
-9,738
Depreciation & amortisation
101
111
114
91
93
Stock-based compensation
596
686
556
497
43
Change in working capital
358
-472
-1,661
-28
1,877
Accounts payable
163
28
-783
-411
1,101
Other working capital
-4,947
-5,014
-10,914
-18,805
-7,744
Net cash provided by operating activities
-4,947
-5,014
-10,912
-18,762
-7,725
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-2
-43
-19
Net cash used for investing activities
0
0
-2
-43
-19
Cash flows from financing activities
Common stock issued
-
-
0
24,070
50,894
Other financing activities
-
-
-
-977
-2,442
Net cash used provided by (used for) financing activities
-
-
0
23,093
48,452
Net change in cash
-4,947
-5,014
-10,914
4,288
40,708
Cash at beginning of period
40,850
42,445
53,359
49,071
8,363
Cash at end of period
35,903
37,431
42,445
53,359
49,071
Free cash flow
Operating cash flow
-4,947
-5,014
-10,912
-18,762
-7,725
Capital expenditure
-
-
-2
-43
-19
Free cash flow
-4,947
-5,014
-10,914
-18,805
-7,744